Intervention: Tocilizumab

Palčić Marija

Croatia
|
2021-2022
  • Adults (18-64 years)
  • Elderly (≥65 years)
  • Hospital
  • SARS-CoV-2
  • Pharmacological intervention
  • Monoclonal antibodies
  • Tocilizumab